← Back to Search

E-Cigarette Flavors for Tobacco Addiction (TEN Trial)

N/A
Recruiting
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre to post-intervention (approximately 10 days)
Awards & highlights

TEN Trial Summary

This trial aims to see if chemicals in e-cigarettes can make them more addictive.

Who is the study for?
This trial is for adults over 21 who regularly use tobacco products like vapes, cigarettes, or cigars and have done so for the last three months. Participants should not be planning to quit tobacco within the next month and must be able to read and write in English.Check my eligibility
What is being tested?
The study is looking at how different flavors added to electronic nicotine delivery systems (ENDS) might change brain function and behavior, potentially affecting addiction levels.See study design
What are the potential side effects?
Since this trial focuses on flavor effects rather than a new medication, specific side effects are not listed. However, general risks associated with using ENDS may apply.

TEN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre to post-intervention (approximately 10 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre to post-intervention (approximately 10 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Absolute reinforcement
Brain reward reactivity

TEN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hexyl AcetateExperimental Treatment1 Intervention
E-cigarette liquid containing hexyl acetate, propylene glycol, vegetable glycerin and methylbutyl acetate with nicotine salt.
Group II: Ethyl AcetateActive Control1 Intervention
E-cigarette liquid containing ethyl acetate, propylene glycol, vegetable glycerin and methylbutyl acetate with nicotine salt.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
495 Previous Clinical Trials
2,798,824 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,681 Total Patients Enrolled
1 Trials studying Tobacco Addiction
450 Patients Enrolled for Tobacco Addiction

Media Library

Hexyl Acetate Clinical Trial Eligibility Overview. Trial Name: NCT05836051 — N/A
Tobacco Addiction Research Study Groups: Hexyl Acetate, Ethyl Acetate
Tobacco Addiction Clinical Trial 2023: Hexyl Acetate Highlights & Side Effects. Trial Name: NCT05836051 — N/A
Hexyl Acetate 2023 Treatment Timeline for Medical Study. Trial Name: NCT05836051 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being added to this research project?

"Clinicaltrials.gov reveals that this clinical trial has concluded recruitment and is not currently seeking participants. The posting was originally created on June 1st, 2023 and the last update occured on April 18th, 2023; however, 111 other trials have ongoing patient enrollment at present."

Answered by AI
~8 spots leftby Jun 2024